E. Zang
- Biochemistry top 5%
- Oncology top 5%
- Cancer Risks and Factors 4
- Cancer Treatment and Pharmacology 3
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 3
- Pharmacology top 5%
-
- Smoking Behavior and Cessation 4
- Diet and metabolism studies 2
-
- Blood donation and transfusion practices 2
-
- Nutritional Studies and Diet 2
-
- Microtubule and mitosis dynamics 2
- Co-authors
- E L WynderGary J. KelloffSrinivasa Reddy BonamKenji TokumoChinthalapally V. RaoJ. H. WeisburgerErnst L. WynderAbraham Rivenson
- Cited by
- BiochemistryOncologyCancer Research
- Journals
- JNCI Journal of the National Cancer Institute (5 papers)Journal of Clinical Oncology (5 papers)Carcinogenesis (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
E. Zang
36 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Biochemistry 162
- Oncology 558
- Cancer Research 300
- Pathology and Forensic Medicine 284
- Pharmacology 235
Countries citing papers authored by E. Zang
This map shows the geographic impact of E. Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Zang more than expected).
Fields of papers citing papers by E. Zang
This network shows the impact of papers produced by E. Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Zang. The network helps show where E. Zang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Zang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2011 | 44 | |
| 3 | 2001 | 31 | |
| 4 | 1998 | 36 | |
| 5 | 1997 | 19 | |
| 6 | 1996 | 40 | |
| 7 | 1996 | 8 | |
| 8 | Differences in Lung Cancer Risk Between Men and Women: Examination of the Evidencebreakdown → | 1996 | 535 |
| 9 | 1995 | 86 | |
| 10 | 1994 | 7 | |
| 11 | 1994 | 23 | |
| 12 | 1994 | 115 | |
| 13 | 1994 | 70 | |
| 14 | 1991 | 62 | |
| 15 | Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. | 1990 | 196 |
| 16 | 1990 | 21 | |
| 17 | 1989 | 49 | |
| 18 | Platelet function abnormalities following plasma perfusion over protein A-silica in cancer patients. | 1988 | 1 |
| 19 | 1987 | 42 | |
| 20 | 1986 | 127 |
About E. Zang
E. Zang is a scholar working on Biochemistry, Oncology, Applied Microbiology and Biotechnology, Hematology and Management of Technology and Innovation, having authored 38 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Risks and Factors (4 papers), Smoking Behavior and Cessation (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Cancer Treatment and Pharmacology (3 papers), Blood donation and transfusion practices (2 papers), Nutritional Studies and Diet (2 papers), Microtubule and mitosis dynamics (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Biochemistry (162 citations), Oncology (558 citations), Cancer Research (300 citations), Pathology and Forensic Medicine (284 citations) and Pharmacology (235 citations). E. Zang has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include E L Wynder, Gary J. Kelloff, Srinivasa Reddy Bonam, Kenji Tokumo, Chinthalapally V. Rao, J. H. Weisburger, Ernst L. Wynder, Abraham Rivenson, Lirio S. Covey and Alvin E. Friedman‐Kien. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Carcinogenesis, Experimental Biology and Medicine and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.